Funding & Awards
 

Telomere Shortening in Cancer and Aging

Miguel GODINHO FERREIRA, Research Director, DR2 CNRS
 

Core funding for the IRCAN is provided by the University Côte d'Azur, the CNRS and the INSERM

 

 

Research projects from the team are supported by:

 

Active

2019-2022: Fondation pour la Recherche Médicale (Équipes FRM) - The gut as an aging initiator organ of zebrafish. EQU201903007804, France.

2019-2020: Université Côte d’Azur Installation Grant - Does aging confer a tumor-prone microenvironment? Action 2 de l'Académie 4.

   

Concluded

2016-2019: Fondation ARC - Establishing anti-telomerase therapeutics for invasive melanoma in zebrafish. PJA 20161205137, France.

2016-2019: FCT - Age as a carcinogen: is telomere-shortening the culprit?. PTDC/BIM-ONC/3402/2014, Portugal.

2012-2017: Howard Hughes Medical Institute International Early Career Scientist, USA.

 

Research teams